{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:19:08Z","timestamp":1789935548343,"version":"4.0.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2892,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Osteomalacia rarely occurs in adult patients with chronic liver disease despite a low serum vitamin D level being reported in up to two-thirds of patients with cirrhosis. In contrast, osteoporosis, which increases the risk of vertebral fractures, occurs in 12%-55% of patients with cirrhosis. Although the prevalence is probably falling, as shown by a fall from 57%-26% in patients with biliary disease requiring liver transplantation over the last 2 decades, it still accounts for significant patient morbidity. Bone density also falls in the first 3 months after liver transplantation, and pretransplant fractures are predictive of posttransplant fractures. Many of the known risk factors for postmenopausal osteoporosis exist in the cirrhotic population, such as excess alcohol intake, steroid use, poor nutrition, and hypogonadism. There is also an increased risk of osteoporosis in patients without cirrhosis, particularly those with hemochromatosis and biliary disease. The diagnosis is made with bone density measurements. The effective treatment is largely based on evidence from postmenopausal osteoporosis as there have been only a few small clinical trials of patients with chronic liver disease. Bisphosphonates are the mainstay of treatment; they have been shown to be effective in biliary disease and are well tolerated. (HEPATOLOGY 2007.)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.21852","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T17:46:27Z","timestamp":1190310387000},"page":"1271-1278","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":188,"title":["Bone disorders in chronic liver disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Jane","family":"Collier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20241201","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis.","volume":"37","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"key":"R2-37-20241201","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"AGA technical review on osteoporosis in hepatic disorders.","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"R3-37-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.50.suppl_1.i1","article-title":"Guidelines on the management of osteoporosis associated with chronic liver disease.","volume":"50","author":"Collier","year":"2002","journal-title":"Gut"},{"key":"R4-37-20241201","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/lt.20160","article-title":"Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism.","volume":"10","author":"Guichelaar","year":"2004","journal-title":"Liver Transpl"},{"key":"R5-37-20241201","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ncpgasthep0637","article-title":"Vitamin D replacement for cirrhosisrelated bone disease.","volume":"3","author":"Crawford","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R6-37-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00298430","article-title":"Vertebral fracture and osteopaenia in chronic alcoholic patients.","volume":"57","author":"Peris","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"R7-37-20241201","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.1840040216","article-title":"Metabolic bone disease in alcoholic cirrhosis: a comparison of the effects of vitamin D2, 25 hydroxyvitamin D or supportive treatment.","volume":"4","author":"Mobarhan","year":"1984","journal-title":"HEPATOLOGY"},{"key":"R8-37-20241201","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/BF02349641","article-title":"Hypogonadism is not related to the etiology of liver cirrhosis.","volume":"30","author":"Kaymakoglu","year":"1995","journal-title":"J Gastroenterol"},{"key":"R9-37-20241201","first-page":"331","article-title":"Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis.","volume":"17","author":"Pares","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R10-37-20241201","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation.","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"R11-37-20241201","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2005.05.034","article-title":"The RANKLOPG system and bone mineral density in patients with chronic liver disease.","volume":"43","author":"Moschen","year":"2005","journal-title":"J Hepatol"},{"key":"R12-37-20241201","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510280315","article-title":"Bone mineral density, serum insulin like growth factor I and bone turnover markers in viral cirrhosis.","volume":"28","author":"GallejoRojo","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R13-37-20241201","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0168-8278(98)80211-0","article-title":"Osteopaenia in rats with liver cirrhosis: beneficial effects of IGF1 treatment.","volume":"28","author":"Cemborain","year":"1998","journal-title":"J Hepatol"},{"key":"R14-37-20241201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jocd.2005.10.001","article-title":"Hyperbilirubinaemia is not a major contributing risk factor to altered bone mineral density in patients with chronic liver disease.","volume":"9","author":"Smith","year":"2006","journal-title":"J Clin Densitom"},{"key":"R15-37-20241201","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archinte.166.12.1256","article-title":"Vitamin K and the prevention of fractures.","volume":"166","author":"Cockayne","year":"2006","journal-title":"Arch Intern Med"},{"key":"R16-37-20241201","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gut.31.1.82","article-title":"Osteoporosis and skeletal fractures in chronic liver disease.","volume":"31","author":"Diamond","year":"1980","journal-title":"Gut"},{"key":"R17-37-20241201","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1440-1746.1996.tb00284.x","article-title":"Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of the cirrhosis?","volume":"11","author":"Chen","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-37-20241201","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","article-title":"Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.","volume":"60","author":"Monegal","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"R19-37-20241201","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0168-8278(98)80253-5","article-title":"Bone disease in patients with sclerosing cholangitis: prevalence, severity and prediction of progression.","volume":"29","author":"Angulo","year":"1998","journal-title":"J Hepatol"},{"key":"R20-37-20241201","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00042737-200012080-00013","article-title":"Incidence of vertebral fracture in the first three months following orthotopic liver transplantation.","volume":"12","author":"Ninkovic","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R21-37-20241201","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1053\/jlts.2003.50242","article-title":"Osteopaenia and osteoporosis in patients with endstage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem.","volume":"9","author":"Carey","year":"2003","journal-title":"Liver Transpl"},{"key":"R22-37-20241201","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/lt.20104","article-title":"Bone mineral density among cirrhotic patients awaiting liver transplantation.","volume":"10","author":"Sokhi","year":"2004","journal-title":"Liver Transpl"},{"key":"R24-37-20241201","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT; longterm followup and predictive factors.","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"key":"R25-37-20241201","first-page":"389","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","volume":"21","author":"Lindor","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R26-37-20241201","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.","volume":"42","author":"Guanabens","year":"2005","journal-title":"J Hepatol"},{"key":"R27-37-20241201","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","article-title":"Fracture risk in people with primary biliary cirrhosis: a populationbased cohort study.","volume":"131","author":"SolaymaniDodaran","year":"2006","journal-title":"Gastroenterology"},{"key":"R28-37-20241201","first-page":"1809","article-title":"Bone and joint involvement in genetic haemochromatosis: role of cirrhosis and iron overload.","volume":"24","author":"Sinigaglia","year":"1997","journal-title":"J Rheumatol"},{"key":"R29-37-20241201","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00198-005-1934-0","article-title":"Bone mineral density in men with genetic hemochromatosis and HFE gene mutations.","volume":"16","author":"Guggenbuhl","year":"2005","journal-title":"Osteoporos Int"},{"key":"R30-37-20241201","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(00)80314-1","article-title":"Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C.","volume":"33","author":"SolisHerruzo","year":"2000","journal-title":"J Hepatol"},{"key":"R31-37-20241201","first-page":"1843","article-title":"World J G","volume":"11","author":"Schiefke","year":"2005","journal-title":"astroenterol"},{"key":"R32-37-20241201","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s001980170051","article-title":"Bone metabolism and gonad function in male patients undergoing liver transplantation: a twoyear longitudinal study.","volume":"12","author":"Floerani","year":"2001","journal-title":"Osteoporos Int"},{"key":"R33-37-20241201","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease.","volume":"45","author":"Pares","year":"2006","journal-title":"J Hepatol"},{"key":"R34-37-20241201","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s005350050250","article-title":"Calcitriol for bone loss in patients with primary biliary cirrhosis.","volume":"34","author":"Shiomi","year":"1999","journal-title":"J Gastroenterol"},{"key":"R35-37-20241201","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.","volume":"98","author":"Guanabens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R36-37-20241201","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebocontrolled study.","volume":"42","author":"Zein","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R37-37-20241201","first-page":"S148","article-title":"Effects of intravenous pamidronate on bone loss after liver transplantation. Abstract.","volume":"78","author":"Monegal","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"R38-37-20241201","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","article-title":"Zoledronic acid prevents bone loss after liver transplantation: a randomized double blind, placebocontrolled trial.","volume":"144","author":"Crawford","year":"2006","journal-title":"Ann Intern Med"},{"key":"R39-37-20241201","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates.","volume":"353","author":"Woo","year":"2005","journal-title":"N Engl J Med"},{"key":"R40-37-20241201","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","article-title":"Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1 year controlled trial.","volume":"19","author":"Pereira","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-37-20241201","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10620-006-8015-x","article-title":"Osteoporosis in primary biliary cirrhosis: a randomised trial of the efficacy and feasibility of estrogenprogestin.","volume":"51","author":"Boone","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R42-37-20241201","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2796.2004.01342.x","article-title":"An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis.","volume":"256","author":"Ormarsdottir","year":"2004","journal-title":"J Intern Med"},{"key":"R43-37-20241201","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","article-title":"Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.","volume":"25","author":"Levy","year":"2005","journal-title":"Liver Int"},{"key":"R44-37-20241201","first-page":"389","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis.","volume":"21","author":"Eastell","year":"1991","journal-title":"HEPATOLOGY"},{"key":"RU45-37-20241201","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(94)90324-7","article-title":"Bone loss after orthotopic liver transplantation.","volume":"97","author":"Meys","year":"1994","journal-title":"Am J Med"},{"key":"RU46-37-20241201","first-page":"148","article-title":"Calcitonin and bisphosphonate treatment in bone loss after liver transplantation.","volume":"60","author":"Valero","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"RU47-37-20241201","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/lt.500040508","article-title":"Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.","volume":"4","author":"Reeves","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"RU48-37-20241201","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","article-title":"Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation.","volume":"357","author":"LeidigBruckner","year":"2001","journal-title":"Lancet"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21852","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200710000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:06:56Z","timestamp":1733040416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200710000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21852","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}